Cargando…
Cancer/testis antigen CAGE mediates osimertinib resistance in non-small cell lung cancer cells and predicts poor prognosis in patients with pulmonary adenocarcinoma
CAGE, a cancer/testis antigen, was originally isolated from the sera of patients with gastric cancers. Previously, we have shown the role of CAGE in resistance to chemotherapy and target therapy. The aim of this study was to investigate the role of CAGE in osimertinib resistance and determine the pr...
Autores principales: | Yeon, Minjeong, Lee, Hankyu, Yeo, Jeongseon, Jeong, Myeong Seon, Jung, Hyun Suk, Lee, Hyerim, Shim, Kyeonghee, Jo, Hyein, Jeon, Doyong, Koh, Jaemoon, Jeoung, Dooil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514060/ https://www.ncbi.nlm.nih.gov/pubmed/37735252 http://dx.doi.org/10.1038/s41598-023-43124-8 |
Ejemplares similares
-
Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy
por: Shim, Kyeonghee, et al.
Publicado: (2023) -
Exosomes: Diagnostic and Therapeutic Implications in Cancer
por: Jo, Hyein, et al.
Publicado: (2023) -
Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance
por: Jo, Hyein, et al.
Publicado: (2023) -
Targeting HDAC6 to Overcome Autophagy-Promoted Anti-Cancer Drug Resistance
por: Jo, Hyein, et al.
Publicado: (2022) -
Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics
por: Jo, Hyein, et al.
Publicado: (2022)